Vitamin A deficiency (VAD), teratogenic, and surgical models of congenital diaphragmatic hernia (CDH)

Area of Science:

• Developmental biology
• Teratology
• Molecular genetics

Background:

• Congenital diaphragmatic hernia (CDH) is a severe birth defect impacting diaphragm and lung development.
• CDH occurs in 0.08–0.45 per 1,000 births, often leading to significant morbidity and mortality.
• The precise etiology of CDH remains largely unknown, necessitating research into its molecular underpinnings.

Purpose of the Study:

• To review teratogenic and surgical models for understanding congenital diaphragmatic hernia (CDH).
• To elucidate the molecular mechanisms of nitrofen's role in inducing CDH and pulmonary hypoplasia.
• To explore the influence of vitamin A and potential teratogen interference on lung and diaphragm development.

Main Methods:

• Focus on teratogenic models, specifically using nitrofen, an herbicide.
• Examination of surgical models to replicate CDH conditions.
• Review of studies investigating anti-inflammatory agents and their link to CDH.
• Analysis of vitamin A's role and teratogen interactions in developmental pathways.

Main Results:

• Nitrofen exposure in models induces CDH and pulmonary hypoplasia, suggesting specific molecular pathways.
• Vitamin A is crucial for normal lung and diaphragm development; disruptions can lead to malformations.
• Teratogens may interfere with vitamin A homeostasis, contributing to CDH pathogenesis.

Conclusions:

• Teratogenic and surgical models provide valuable insights into CDH molecular mechanisms.
• Understanding nitrofen's effects and vitamin A's role can illuminate CDH etiology.
• Further research using these models is essential for developing effective therapeutic strategies for CDH.